Support and Resistance Levels
Past performance
About Auro Laboratories Ltd Auro Laboratories Ltd, established in 1992 and based in Mumbai, specializes in manufacturing generic Active Pharmaceutical Ingredients (APIs), with a primary focus on anti-diabetic medications like Metformin HCL and Glibenclamide. The company operates a state-of-the-art facility in Palghar, Maharashtra, which adheres to cGMP norms and boasts certifications from Indian and European authorities, including ISO 9001:2000, WHO-cGMP, and a Certificate of Suitability from the EDQM. Auro Laboratories plans to expand its Metformin HCL production capacity from 1800 MTPA to 3600 MTPA to meet the growing demand in the fast-expanding anti-diabetic segment.
The company also engages in toll and custom manufacturing of APIs and intermediates, catering to a diverse international market with exports primarily to Southeast Asia, the Middle East, and Europe, including countries such as Germany, the UK, and Brazil. Auro Laboratories' commitment to quality and strategic expansion positions it as a competitive player in the global pharmaceutical industry.